ALXN - Alexion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 529.35B
Enterprise Value 330.56B
Trailing P/E 70.30
Forward P/E 112.20
PEG Ratio (5 yr expected) 10.97
Price/Sales (ttm)6.76
Price/Book (mrq)3.02
Enterprise Value/Revenue 37.04
Enterprise Value/EBITDA 614.16

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 9.59%
Operating Margin (ttm)41.06%

Management Effectiveness

Return on Assets (ttm)8.01%
Return on Equity (ttm)4.43%

Income Statement

Revenue (ttm)4.34B
Revenue Per Share (ttm)19.45
Quarterly Revenue Growth (yoy)22.50%
Gross Profit (ttm)3.76B
EBITDA 2.16B
Net Income Avi to Common (ttm)416.4M
Diluted EPS (ttm)1.86
Quarterly Earnings Growth (yoy)136.00%

Balance Sheet

Total Cash (mrq)1.67B
Total Cash Per Share (mrq)7.44
Total Debt (mrq)2.88B
Total Debt/Equity (mrq)29.68
Current Ratio (mrq)3.87
Book Value Per Share (mrq)43.29

Cash Flow Statement

Operating Cash Flow (ttm)556.6M
Levered Free Cash Flow (ttm)1.06B

Trading Information

Stock Price History

Beta (3Y Monthly) 1.70
52-Week Change 310.08%
S&P500 52-Week Change 35.24%
52 Week High 3141.86
52 Week Low 392.56
50-Day Moving Average 3134.24
200-Day Moving Average 3123.90

Share Statistics

Avg Vol (3 month) 31.33M
Avg Vol (10 day) 31.23M
Shares Outstanding 5224.24M
Float 223.77M
% Held by Insiders 10.31%
% Held by Institutions 196.77%
Shares Short (Apr 30, 2019) 43.69M
Short Ratio (Apr 30, 2019) 42.74
Short % of Float (Apr 30, 2019) 41.95%
Short % of Shares Outstanding (Apr 30, 2019) 41.64%
Shares Short (prior month Mar 29, 2019) 44M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/2
Last Split Date 3May 23, 2011